Adaptive Biotechnologies Corp reports results for the quarter ended in June - Earnings Summary

Adaptive Biotechnologies

02/08/2023 22:46

* Adaptive Biotechnologies Corp  ADPT.OQ  reported a
quarterly
adjusted loss of 33 cents​​ per share for the quarter ended in
June. The mean expectation of ten analysts for the quarter was
for a loss of 35 cents per share.
    * Revenue rose 12.1% to $48.93 million from a year ago;
analysts
expected $44.89 million. 
    * Adaptive Biotechnologies Corp's reported EPS for the
quarter was
a loss of 33 cents​.
    * The mean earnings estimate of analysts had fallen by
about 8.4%
in the last three months.​ 
    * In the last 30 days, there have been no negative revisions
of
earnings estimates 
    * Adaptive Biotechnologies Corp shares had risen by 23.0%
this
quarter and gained 8.0% so far this year.
    * The company reported a quarterly loss of $47.81 million.
    * Wall Street's median 12-month price target for Adaptive
Biotechnologies Corp is $12.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," 2
"hold" and 1 "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 2 at 09:45 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -0.35          -0.33          Beat
 Mar. 31 2023      -0.38          -0.40          Missed
 Dec. 31 2022      -0.35          -0.28          Beat
 Sep. 30 2022      -0.38          -0.32          Beat